Risperidone

• A prospective, randomized, and controlled study comparing two treatment strategies (Dose REduction of Antipsychotics vs. Maintenance treatme… Pending
  2023-509558-80-00 Phase III 1 country Les Hopitaux Universitaires De Strasbourg
• Clinical trial to study the effect of an already authorized drug on other pathologies by administering it to people with a recent diagnosis … Recruiting
  2024-519778-38-00 Phase II/III 1 country Fundacion Para La Gestion De La Investigacion En Salud De Sevilla
• A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for schizophrenia compared to t… Recruiting
  2023-506602-39-00 Phase IV 4 countries Universitair Medisch Centrum Utrecht
• Safety and pharmacokinetics of antipsychotics in children 2: Studying TDM in an RCT Recruiting
  2024-511568-96-00 Phase IV 2 countries Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
• A New Intervention for Implementation of Pharmacogenetics in Psychiatry Recruiting
  2023-509680-25-00 Phase IV 3 countries Parnassia Groep B.V.
• Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis (SchizOMICS) Recruiting
  2024-516768-28-00 Phase IV 1 country Consorcio Centro De Investigacion Biomedica En Red
• HAMLETT. Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A study comparing continuation versus discontinuatio… Ended
  2024-518769-80-00 Phase IV 1 country Universitair Medisch Centrum Groningen
• Cannabidiol for treatment of non-affective psychosis and cannabis use Ended
  2024-517630-18-00 Phase II/III 1 country Region Hovedstaden

Showing 1–8 of 8 trials